Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: An interrupted time-series analysis

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 6, 2008, Pages 1422-1429

  Chaberny, Iris F ^a   Schwab, Frank ^b   Ziesing, Stefan ^a   Suerbaum, Sebastian ^a   Gastmeier, Petra ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Infection control; MRSA; Prevention measures; Reduction; Screening policies

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED STUDY; HEALTH CARE POLICY; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; QUASI EXPERIMENTAL STUDY; RISK REDUCTION; SCREENING TEST; STAPHYLOCOCCUS INFECTION; SURGICAL WARD; TIME SERIES ANALYSIS;

CROSS INFECTION; DIAGNOSTIC TESTS, ROUTINE; HOSPITAL DEPARTMENTS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; REGRESSION ANALYSIS; STAPHYLOCOCCAL INFECTIONS;

EID: 56649123522     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn373     Document Type: Article

References (36)

1. Aboelela SW, Saiman L, Stone P et al. Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: A systematic review of the literature. Am J Infect Control 2006; 34: 484-94.
2. Farr BM. What to think if the results of the National Institutes of Health randomized trial of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus control measures are negative (and other advice to young epidemiologists): A review and an au revoir. Infect Control Hosp Epidemiol 2006; 27: 1096-106.
3. Tiemersma EW, Bronzwaer SL, Lyytikainen O et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004; 10: 1627-34.
4. Davis KA, Stewart JJ, Crouch HK et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39: 776-82.
5. Chaberny IF, Ziesing S, Mattner F et al. The burden of MRSA in four German university hospitals. Int J Hyg Environ Health 2005; 208: 447-53.
6. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001; 22: 99-104.
7. Nathwani D. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: Does reducing the length of hospital stay matter? J Antimicrob Chemother 2003; 51 Suppl 2: Ii37-44.
8. Plowman R, Graves N, Griffin MA et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001; 47: 198-209.
9. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20: 408-11.
10. Cosgrove SE, Qi Y, Kaye KS et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: Mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-74.
11. Cosgrove SE, Sakoulas G, Perencevich EN et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-9.
12. Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592-8.
13. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: A meta-analysis. Med J Aust 2001; 175: 264-7.
14. Tomic V, Svetina Sorli P, Trinkaus D et al. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med 2004; 164: 2038-43.
15. Farr BM. Methicillin-resistant Staphylococcus aureus infections. Curr Infect Dis Rep 1999; 1: 328-33.
16. Lucet JC, Paoletti X, Lolom I et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005; 31: 1051-7.
17. Huang SS, Yokoe DS, Hinrichsen VL et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006; 43: 971-8.
18. Clancy M, Graepler A, Wilson M et al. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 2006; 27: 1009-17.
19. Chaberny IF, Bindseil A, Sohr D et al. A point-prevalence study for MRSA in a German university hospital to identify patients at risk and to evaluate an established screening procedure. Infection 2008; 36 doi: 10.1007/s15010-008-7436-1.
20. Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis 2007; 7: 282-8.
21. Chaberny IF, Sohr D, Ruden H et al. Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals. Infect Control Hosp Epidemiol 2007; 28: 446-52.
22. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fourteenth Informational Supplement M100-S14. NCCLS, Wayne, PA, USA, 2004.
23. Fernandez-Perez C, Tejada J, Carrasco M. Multivariate time series analysis in nosocomial infection surveillance: A case study. Int J Epidemiol 1998; 27: 282-8.
24. Ramsay C, Brown E, Hartman G et al. Room for improvement: A systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764-71.
25. Wagner AK, Soumerai SB, Zhang F et al. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002; 27: 299-309.
26. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: Interrupted time series with segmented regression analysis. J Antimicrob Chemother 2003; 52 842-8.
27. Durbin J, Watson GS. Testing for serial correlation in least square regression. Biometrika 1951; 37: 409-28.
28. Furuno JP, Harris AD, Wright MO et al. Value of performing active surveillance cultures on intensive care unit discharge for detection of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28: 666-70.
29. Khoury J, Jones M, Grim A et al. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26: 616-21.
30. Warren DK, Guth RM, Coopersmith CM et al. Impact of a methicillin-resistant Staphylococcus aureus active surveillance program on contact precaution utilization in a surgical intensive care unit. Crit Care Med 2007; 35: 430-4.
31. West TE, Guerry C, Hiott M et al. Effect of targeted surveillance for control of methicillin-resistant Staphylococcus aureus in a community hospital system. Infect Control Hosp Epidemiol 2006; 27: 233-8.
32. Gould IM, Mackenzie FM, MacIennan G et al. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 2007; 29: 536-43.
33. Mahamat A, MacKenzie FM, Brooker K et al. Impact of infection control interventions and antibiotic use on hospital MRSA: A multivariate interrupted time-series analysis. Int J Antimicrob Agents 2007; 30: 169-76.
34. van Trijp MJ, Melles DC, Hendriks WD et al. Successful control of widespread methicillin-resistant Staphylococcus aureus colonization and infection in a large teaching hospital in the Netherlands. Infect Control Hosp Epidemiol 2007; 28: 970-5.
35. Charbonneau P, Parienti JJ, Thibon P et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: A quasi experimental study. Clin Infect Dis 2006; 42: 778-84.
36. Madaras-Kelly KJ, Remington RE, Lewis PG et al. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol 2006; 27: 155-69.